FrancophonIA/ELRC3.0 huggingface dataset:
English: In clinical trials in elderly patients with dementia, olanzapine treatment was associated with a higher incidence of death and cerebrovascular adverse reactions compared to placebo (see section 4.4).
Slovenian: Dodatne informacije glede posebnih skupin bolnikov V kliničnih preizkušanjih na starejših bolnikih z demenco je bilo zdravljenje z olanzapinom v primerjavi s placebom povezano z večjo smrtnostjo in pogostejšimi možganskožilnimi neželenimi dogodki (gl. poglavje 4.4).
English: Gradual tapering of the dose should be considered when discontinuing olanzapine.
Slovenian: Med ukinjanjem olanzapina je treba odmerek zmanjševati postopno.
English: Caution should be used if olanzapine is being administered concomitantly with medicinal products known to increase QTc interval (see section 4.4).
Slovenian: Če predpisujemo olanzapin sočasno z zdravili, za katera je znano, da podaljšujejo interval QTc, je potreba previdnost (gl. poglavje 4.4).
English: Gynaecomastia/breast enlargement in males
Slovenian: Ginekomastija/ povečanje dojk pri moških
English: In these trials, patients were initially required to be stable on the lowest effective dose of anti-Parkinsonian medicinal products (dopamine agonist) and to remain on the same anti-Parkinsonian medicinal products and dosages throughout the study.
Slovenian: Zdravstveno stanje bolnikov je bilo treba najprej ustaliti ob prejemanju najmanjšega učinkovitega odmerka antiparkinsonskih zdravil (dopaminskih agonistov).
English: If you suddenly stop taking Zalasta, symptoms such as sweating, unable to sleep, tremor, anxiety or nausea and vomiting might occur.
Slovenian: Če nenadno prenehate jemati zdravilo Zalasta, se lahko pojavijo simptomi, kot so znojenje, nespečnost, tresenje, občutek tesnobe ali slabost in bruhanje.
English: It may be harmful for patient with phenylketonuria (PKU).
Slovenian: Lahko škoduje ljudem s fenilketonurijo.
English: Since the orodispersible tablet is fragile, it should be taken immediately on opening the blister.
Slovenian: Ker je krhka, jo je treba dati v usta takoj, ko bolnik odpre pretisni omot.
English: - The other ingredients are lactose monohydrate, powdered cellulose, pregelatinised maize starch, maize starch, colloidal anhydrous silica, magnesium stearate.
Slovenian: - Druge sestavine zdravila (pomožne snovi) so laktoza monohidrat, uprašena celuloza, predgelirani škrob, koruzni škrob, brezvodni koloidni silicijev dioksid, magnezijev stearat.
English: Zalasta 7.5 mg tablets Each tablet contains 121.3 mg lactose.
Slovenian: Zalasta 7,5 mg tablete Ena tableta vsebuje 121,3 mg laktoze.
English: Zalasta 5 mg tablets Each tablet contains 80.9 mg lactose.
Slovenian: Zalasta 5 mg tablete Ena tableta vsebuje 80,9 mg laktoze.
English: However, caution should be exercised when olanzapine is prescribed with medicines known to increase QTc interval, especially in the elderly, in patients with congenital long QT syndrome, congestive heart failure, heart hypertrophy, hypokalaemia or hypomagnesaemia.
Slovenian: Na to moramo še posebej paziti pri starejših, pri bolnikih s prirojenim sindromom dolgega intervala QT, kongestivnim srčnim popuščanjem, srčno hipertrofijo, hipokaliemijo ali hipomagneziemijo.
English: Zalasta 2.5 mg tablets Each tablet contains 40.4 mg lactose.
Slovenian: Zalasta 2,5 mg tablete Ena tableta vsebuje 40,4 mg laktoze.
English: Hold the blister at the edges and separate one blister cell from the rest of the blister by gently tearing along the perforations around it.
Slovenian: Primite pretisni omot na robovih in vzdolž perforacij odtrgajte en pretisni razdelek.
English: In most of these cases, a history of seizures or risk factors for seizures was reported.
Slovenian: Večina teh bolnikov je imela napade že v preteklosti ali pa so bili pri njih prisotni dejavniki tveganja za epileptični napad.
English: Zalasta contains aspartame
Slovenian: Zdravilo Zalasta vsebuje aspartam
English: Following short term treatment (median duration 22 days), weight gain ≥ 7 % of baseline body weight (kg) was very common (40.6 %), ≥ 15 % of baseline body weight was common (7.1 %) and ≥ 25 % was common (2.5 %).
Slovenian: Povečanje telesne mase (kg) za ≥ 7 % glede na izhodiščno je bilo pri kratkotrajnem zdravljenju (srednje trajanje 22 dni) zelo pogosto (40,6 %), za ≥ 15 % pogosto (7,1 %) in za ≥ 25 % občasno (2,5 %).
English: Patients should be closely monitored during this period.
Slovenian: Med zdravljenjem z antipsihotiki je treba bolnike skrbno opazovati.
English: If you stop taking Zalasta
Slovenian: Če ste prenehali jemati zdravilo Zalasta
English: During treatment with olanzapine, adolescents gained significantly more weight compared with adults.
Slovenian: Telesna masa se je med zdravljenjem pri mladostnikih pomembno povečala v primerjavi z odraslimi.
English: Changes in fasting triglycerides from borderline at baseline (≥ 1.69 mmol/l-< 2.26 mmol/l) to high (≥ 2.26 mmol/l) were very common.
Slovenian: Spremembe vrednosti trigliceridov na tešče z mejnih izhodiščnih vrednosti (od ≥ 1,69 do < 2,26 mmol/l) na visoke (≥ 2,26 mmol/l) so bile zelo pogoste.
English: Zalasta 15 mg tablets Each tablet contains 242.7 mg lactose.
Slovenian: Zalasta 15 mg tablete Ena tableta vsebuje 242,7 mg laktoze.
English: Olanzapine was used as a flexible dose starting with 2.5 and ranging up to 20 mg/day.
Slovenian: Zdravljenje so začeli z 2,5 mg in odmerek postopno povečevali do 20 mg na dan.
English: Uncommon side effects (may affect up to 1 in 100 people) include hypersensitivity (e.g. swelling in the mouth and throat, itching, rash); diabetes or the worsening of diabetes, occasionally associated with ketoacidosis (ketones in the blood and urine) or coma; seizures, usually associated with a history of seizures (epilepsy); muscle stiffness or spasms (including eye movements); restless legs syndrome; problems with speech; stuttering; slow heart rate; sensitivity to sunlight; bleeding from the nose; abdominal distension; memory loss or forgetfulness; urinary incontinence; lack of ability to urinate; hair loss; absence or decrease in menstrual periods; and changes in breasts in males and females such as an abnormal production of breast milk or abnormal growth.
Slovenian: Občasni neželeni učinki (pojavijo se lahko pri največ 1 od 100 bolnikov) vključujejo preobčutljivost (npr. otekanje v ustih in grlu, srbenje, izpuščaj), sladkorno bolezen ali poslabšanje sladkorne bolezni, občasno povezano s ketoacidozo (ketoni v krvi in urinu) ali komo, krče, običajno povezane s krči (epileptičnimi napadi) v preteklosti, mišično okorelost ali krče (vključno z obračanjem zrkel), sindrom nemirnih nog, težave pri govoru, jecljanje, upočasnjen srčni utrip, občutljivost za sončno svetlobo, krvavitev iz nosa, trebušno distenzijo, izgubo spomina ali pozabljivost, urinsko inkontinenco, težave pri mokrenju,izgubo las, odsotnost ali zmanjšanje menstruacij ter spremembe na prsih pri moških in ženskah, kot na primer nenormalno nastajanje mleka v prsih ali nenormalna rast.
English: Caution should be exercised in patients with low leukocyte and/or neutrophil counts for any reason, in patients receiving medicines known to cause neutropenia, in patients with a history of druginduced bone marrow depression/toxicity, in patients with bone marrow depression caused by concomitant illness, radiation therapy or chemotherapy and in patients with hypereosinophilic conditions or with myeloproliferative disease.
Slovenian: Previdnost je prav tako potrebna pri bolnikih, ki so imeli v preteklosti težave zaradi zavrtega delovanja kostnega mozga, ki so ga povzročila zdravila, toksična za kostni mozeg, pri bolnikih z zavrtim delovanjem kostnega mozga zaradi sočasne bolezni, obsevanja ali kemoterapije in pri bolnikih s hipereozinofilnimi stanji ali z mieloproliferativno boleznijo.
English: 7 tablets 14 tablets 28 tablets 35 tablets 56 tablets 70 tablets
Slovenian: 7 tablet 14 tablet 28 tablet 35 tablet 56 tablet 70 tablet
English: Olanzapine reduced a conditioned avoidance response, a test indicative of antipsychotic activity, at doses below those producing catalepsy, an effect indicative of motor side-effects.
Slovenian: Gre za test, ki pokaže antipsihotično delovanje pri manjših odmerkih od tistih, ki povzročijo katalepsijo, tj. učinek, ki kaže na motorične neželene učinke.
English: Rare cases reported as NMS have also been received in association with olanzapine.
Slovenian: O redkih primerih tega sindroma so poročali tudi v povezavi z jemanjem olanzapina.
English: Respiratory, thoracic and mediastinal disorders
Slovenian: Bolezni dihal, prsnega koša in mediastinalnega prostora Epistaksa
English: Observed for fasting normal levels at baseline (< 1.016 mmol/l) which increased to high (≥ 1.467 mmol/l) and changes in fasting triglycerides from borderline at baseline (≥ 1.016 mmol/l-< 1.467 mmol/l) to high (≥ 1.467 mmol/l).
Slovenian: Vrednosti trigliceridov na tešče so se z mejnih osnovnih vrednosti (≥ 1,016 mmol/l do < 1,467 mmol/l) spremenile na visoke (≥ 1,467 mmol/l).
English: Zalasta 20 mg tablets EU/1/07/415/027-031
Slovenian: Zalasta 20 mg tablete EU/1/07/415/027-031
English: 14 tablets 28 tablets 35 tablets 56 tablets 70 tablets
Slovenian: 14 tablet 28 tablet 35 tablet 56 tablet 70 tablet
English: ─ The use of Zalasta in elderly patients with dementia is not recommended as it may have serious side effects ─ Medicines of this type may cause unusual movements mainly of the face or tongue.
Slovenian: - Uporaba zdravila Zalasta ni priporočljiva pri starejših bolnikih z demenco, saj lahko povzroči resne neželene učinke.
English: This medicine contains 0.75 mg aspartame in each 7.5 mg orodispersible tablet.
Slovenian: To zdravilo vsebuje 0,75 mg aspartama v eni 7,5 mg orodisperzibilni tableti.
English: Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements (dyskinesias); constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.
Slovenian: Pogosti neželeni učinki (pojavijo se lahko pri največ 1 od 10 bolnikov) vključujejo spremembe ravni nekaterih krvnih celic, maščob v krvnem obtoku in v začetnih obdobjih zdravljenja, začasno povišanje jetrnih encimov, zvišane ravni sladkorjev v krvi in urinu, zvišanja v ravni sečne kisline in kreatinfosfokinaze v krvi, večji občutek lakote, omotico, nemirnost, tresenje, nenavadne gibe (diskinezijo), zaprtje, suha usta, izpuščaj, izgubo moči, hudo utrujenost, zadrževanje vode, ki vodi v otekanje rok, gležnjev ali nog ter spolne disfunkcije, kot na primer zmanjšan libido pri moških in ženskah ter erektilna disfunkcija pri moških.
English: Observed for fasting normal levels at baseline (< 5.56 mmol/l) which increased to high (≥ 7 mmol/l).
Slovenian: Opazovano pri normalnih osnovnih vrednostih na tešče (< 5,56 mmol/l), ki so se zvišale na visoke (≥ 7 mmol/l).
English: Olanzapine is metabolized in the liver by conjugative and oxidative pathways.
Slovenian: V jetrih se presnavlja s konjugacijo in oksidacijo.
English: You should not take this medicine when pregnant unless you have discussed this with your doctor.
Slovenian: Zdravila ne prenehajte jemati, razen če vam to naroči vaš zdravnik.
English: A lower starting dose of olanzapine should be considered in patients who are using fluvoxamine or any other CYP1A2 inhibitors, such as ciprofloxacin.
Slovenian: Pri bolnikih, ki jemljejo fluvoksamin ali druge zaviralce CYP1A2, npr. ciprofloksacin, je treba razmisliti o manjšem začetnem odmerku olanzapina.
English: Reversible neutropenia, thrombocytopenia, or anaemia developed in a few dogs treated with 8 or 10 mg/kg/day (total olanzapine exposure [AUC] is 12- to 15-fold greater than that of a man given a 12-mg dose).
Slovenian: Pri nekaj psih, ki so jim dajali 8 ali 10 mg/kg na dan (celotna izpostavljenost olanzapinu je bila 12- do 15-krat večja kot pri človeku, ki dobi 12-miligramski odmerek), se je razvila reverzibilna nevtropenija, trombocitopenija ali anemija.
English: Observed for fasting normal levels at baseline (< 5.17 mmol/l) which increased to high (≥ 6.2 mmol/l).
Slovenian: Opazovano pri normalnih osnovnih vrednostih na tešče (< 5,17 mmol/l), ki so se zvišale na visoke (≥ 6,2 mmol/l).
English: especially in early treatment (see section
Slovenian: (ALT, AST), posebno na začetku zdravljenja (glejte poglavje 4.4)
English: What Zalasta looks like and contents of the pack Zalasta 5 mg, 7.5 mg, 10 mg, 15 mg and 20 mg orodispersible tablets are: round, slightly biconvex, yellow marbled tablets with possible individual spots.
Slovenian: Zalasta orodisperzibilne tablete po 5 mg, 7,5 mg, 10 mg, 15 mg ali 20 mg so okrogle, rahlo izbočene, rumene barve z morebitnimi posameznimi rumenimi pikami.
English: Zalasta 20 mg tablets
Slovenian: Zalasta 20 mg tablete
English: Photosensitivity reaction Alopecia
Slovenian: Fotosenzitivnostne reakcije
English: The mean increase in olanzapine Cmax following fluvoxamine was 54% in female non-smokers and 77% in male smokers.
Slovenian: Po dajanju fluvoksamina je bilo srednje povečanje največje koncentracije pri nekadilkah 54-odstotno, pri kadilcih pa 77-odstotno, srednje povečanje obsega absorpcije olanzapina pa je bilo 52- oziroma 108-odstotno.
English: In clinical trials, worsening of Parkinsonian symptomatology and hallucinations were reported very commonly and more frequently than with placebo (see section 4.8), and olanzapine was not more effective than placebo in the treatment of psychotic symptoms.
Slovenian: V kliničnih preizkušanjih so o poslabšanju parkinsonske simptomatike in halucinacijah poročali zelo pogosto in pogosteje kot pri placebu (gl. poglavje 4.8).
English: Zalasta 5 mg tablets EU/1/07/415/006-010
Slovenian: Zalasta 5 mg tablete EU/1/07/415/006-010
English: Very common: Sedation (including: hypersomnia, lethargy, somnolence).
Slovenian: Bolezni živčevja zelo pogosti: sedacija (vključno s hipersomnijo, letargijo, zaspanostjo) Bolezni prebavil pogosti: suha usta
English: Seizures
Slovenian: Jecljanje
English: Your mouth should be empty before placing the tablet on the tongue.
Slovenian: Ko tableto položite na jezik, v ustih ne smete imeti hrane.
English: Zalasta 7.5 mg orodispersible tablets Each orodispersible tablet contains 0.75 mg aspartame.
Slovenian: Zalasta 7,5 mg orodisperzibilne tablete Ena orodisperzibilna tableta vsebuje 0,75 mg aspartama.
English: Zalasta 15 mg tablets EU/1/07/415/022-026
Slovenian: Zalasta 15 mg tablete EU/1/07/415/022-026
English: Transient, asymptomatic elevations of hepatic aminotransferases, ALT, AST have been seen commonly, especially in early treatment.
Slovenian: Pogosto so opažali prehodna asimptomatska zvišanja vrednosti jetrnih aminotransferaz, (alaninske aminotransferaze - ALT, aspartatne aminotransferaze - AST), posebno na začetku zdravljenja.
English: Zalasta 7.5 mg tablets
Slovenian: Zalasta 7,5 mg tablete
English: This medicine contains 2.00 mg aspartame in each 20 mg orodispersible tablet.
Slovenian: To zdravilo vsebuje 2,00 mg aspartama v eni 20 mg orodisperzibilni tableti.
English: Signs of oral toxicity in rodents were characteristic of potent neuroleptic compounds: hypoactivity, coma, tremors, clonic convulsions, salivation, and depressed weight gain.
Slovenian: Akutna toksičnost (toksičnost po enkratnem odmerku) Pri glodavcih so se po peroralnem dajanju pojavili znaki toksičnosti, značilni za močne antipsihotične spojine: hipoaktivnost, koma, tresenje, klonični krči, slinjenje in zmanjšano pridobivanje telesne mase.
English: Zalasta 2.5 mg tablets EU/1/07/415/001-005
Slovenian: Zalasta 2,5 mg tablete EU/1/07/415/001-005
English: • Schizophrenia, a disease with symptoms such as hearing, seeing or sensing things which are not there, mistaken beliefs, unusual suspiciousness, and becoming withdrawn.
Slovenian: Zdravilo Zalasta spada v skupino zdravil, imenovanih antipsihotiki, in se uporablja za zdravljenje naslednjih bolezni: - shizofrenije, bolezni s simptomi, kot so prisluhi, prividi ali občutki, ki niso povezani z realnostjo, zmotna prepričanja, nenavadna sumničavost in postopno izogibanje socialnim stikom.
English: ─ High blood sugar and high levels of fat (triglycerides and cholesterol) have been seen in patients taking Zalasta.
Slovenian: - Pri bolnikih, ki so jemali zdravilo Zalasta, so opazili visok nivo sladkorja v krvi in visok nivo maščob (trigliceridov in holesterola).
English: Zalasta 7.5 mg tablets EU/1/07/415/011-015
Slovenian: Zalasta 7,5 mg tablete EU/1/07/415/011-015
English: Lactose monohydrate Powdered cellulose Pregelatinised maize starch Maize starch
Slovenian: 6.1 Seznam pomožnih snovi laktoza monohidrat uprašena celuloza predgelirani koruzni škrob koruzni škrob brezvodni koloidni silicijev dioksid magnezijev stearat
English: Tardive Dyskinesia
Slovenian: Trebušna distenzija
English: • blood clots in the veins (an uncommon side effect that may affect up to 1 in 100 people) especially in the legs (symptoms include swelling, pain, and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing.
Slovenian: Takoj obvestite svojega zdravnika, če opazite: - nenavadne zgibke (pogost neželeni učinek, ki se lahko pojavi pri največ 1 od 10 bolnikov), posebno v mišicah obraza ali jezika; - krvne strdke v venah (občasen neželeni učinek, ki se lahko pojavi pri največ 1 od 100 bolnikov), posebej v nogah (simptomi vključujejo otekanje, bolečino in rdečino na nogah), ki lahko po žilah potujejo v pljuča ter povzročijo bolečino v pljučih in težave z dihanjem.
English: Zalasta 10 mg orodispersible tablets Each orodispersible tablet contains 1.00 mg aspartame.
Slovenian: Zalasta 10 mg orodisperzibilne tablete Ena orodisperzibilna tableta vsebuje 1,00 mg aspartama.
English: This medicine contains 1.50 mg aspartame in each 15 mg orodispersible tablet.
Slovenian: To zdravilo vsebuje 1,50 mg aspartama v eni 15 mg orodisperzibilni tableti.
English: People with this disease may also feel depressed, anxious or tense.
Slovenian: Ljudje s to boleznijo se lahko počutijo tudi depresivno, občutijo tesnobo ali napetost; - zmernih do resnejših maničnih epizod, bolezni s simptomi razburjenja ali evforije.
English: Metabolism and nutrition disorders Weight gain
Slovenian: Presnovne in prehranske motnje Povečanje telesne mase
English: Zalasta 15 mg orodispersible tablets Each orodispersible tablet contains 1.50 mg aspartame.
Slovenian: Zalasta 15 mg orodisperzibilne tablete Ena orodisperzibilna tableta vsebuje 1,50 mg aspartama.
English: Zalasta 20 mg orodispersible tablets Each orodispersible tablet contains 2.00 mg aspartame.
Slovenian: Zalasta 20 mg orodisperzibilne tablete Ena orodisperzibilna tableta vsebuje 2,00 mg aspartama.
English: This medicine contains 1.00 mg aspartame in each 10 mg orodispersible tablet.
Slovenian: To zdravilo vsebuje 1,00 mg aspartama v eni 10 mg orodisperzibilni tableti.
English: Since olanzapine is metabolised by CYP1A2, substances that can specifically induce or inhibit this isoenzyme may affect the pharmacokinetics of olanzapine.
Slovenian: Možna medsebojna delovanja, ki vplivajo na olanzapin Olanzapin se presnavlja z izoencimom 1A2 citokroma P450 (CYP1A2), zato lahko snovi, ki specifično povečajo ali zavirajo delovanje tega izoencima, vplivajo na farmakokinetiko olanzapina.
English: Zalasta 5 mg orodispersible tablets Each orodispersible tablet contains 0.50 mg aspartame.
Slovenian: Zalasta 5 mg orodisperzibilne tablete Ena orodisperzibilna tableta vsebuje 0,50 mg aspartama.
English: Changes in fasting glucose from borderline at baseline (≥ 5.56-< 7 mmol/l) to high (≥ 7 mmol/l) were very common.
Slovenian: Zelo pogoste so bile spremembe vrednosti glukoze na tešče z mejnih osnovnih vrednosti (≥ 5,56 mmol/l do < 7 mmol/l) na visoke (≥ 7 mmol/l).
English: Zalasta 2.5 mg tablets
Slovenian: Zalasta 2,5 mg tablete
English: Orodispersible tablet.
Slovenian: Tableto zvrnite iz pretisnega omota.
English: Pregnancy
Slovenian: Mladostniki
English: Each orodispersible tablet contains 7.5 mg olanzapine.
Slovenian: Ena orodisperzibilna tableta vsebuje 7,5 mg olanzapina.
English: Changes in total fasting cholesterol levels from borderline at baseline (≥ 5.17-< 6.2 mmol/l) to high (≥ 6.2 mmol/l) were very common.
Slovenian: Zelo pogoste so bile spremembe vrednosti skupnega holesterola na tešče z mejnih osnovnih vrednosti (≥ 5,17 mmol/l do < 6,2 mmol/l) na visoke (≥ 6,2 mmol/l).
English: A lower starting dose (5 mg) should be considered for such patients.
Slovenian: Bolniki z okvarjenim ledvičnim in/ali jetrnim delovanjem Te bolnike začnite zdraviti z manjšimi odmerki (5 mg).
English: Changes in total fasting cholesterol levels from normal at baseline (< 4.39 mmol/l) to high (≥ 5.17 mmol/l) were observed commonly.
Slovenian: Pogosto so opazovali spremembe vrednosti skupnega holesterola na tešče, ki so se z normalnih osnovnih vrednosti (< 4,39 mmol/l) zvišale na visoke (≥ 5,17 mmol/l).
English: Zalasta 10 mg tablets
Slovenian: Zalasta 10 mg tablete
English: Postural hypotension was infrequently observed in the elderly in olanzapine clinical trials.
Slovenian: Posturalna hipotenzija V kliničnih preizkušanjih z olanzapinom so pri starejših bolnikih redko poročali o posturalni hipotenziji.
English: Observed for fasting normal levels at baseline (< 1.69 mmol/l) which increased to high (≥ 2.26 mmol/l).
Slovenian: Učinek so opazili pri normalnih izhodiščnih vrednostih na tešče (< 1,69 mmol/l), ki so se povečale (≥ 2,26 mmol/).
English: Colloidal anhydrous silica Magnesium stearate
Slovenian: 6.1 Seznam pomožnih snovi manitol mikrokristalna celuloza krospovidon hidroksipropilceluloza aspartam kalcijev silikat magnezijev stearat
English: Zalasta 15 mg orodispersible tablets EU/1/07/415/047-051
Slovenian: Zalasta 15 mg orodisperzibilne tablete EU/1/07/415/047-051
English: Each tablet contains 2.5 mg olanzapine.
Slovenian: Ena tableta vsebuje 2,5 mg olanzapina.
English: Seizures where in most cases a history of seizures or risk factors for seizures were reported
Slovenian: Epileptični napadi, pri katerih so jih v večini primerov imeli že kdaj prej ali so poročali o dejavnikih tveganja za epileptične napade Distonija (vključno z okulogiracijo) Tardivne diskinezije
English: Activated charcoal reduces the bioavailability of oral olanzapine by 50 to 60% and should be taken at least 2 hours before or after olanzapine.
Slovenian: Zaužiti ga je treba vsaj dve uri pred olanzapinom ali vsaj dve uri po njem.
English: Zalasta 15 mg tablets
Slovenian: Zalasta 15 mg tablete
English: Acute symptoms such as sweating, insomnia, tremor, anxiety, nausea, or vomiting have been reported rarely ≥ 0.01% and < 0.1%) when olanzapine is stopped abruptly.
Slovenian: Redko (≥ 0,01 % in < 0,1 %) so pri nenadni prekinitvi zdravljenja z olanzapinom poročali o akutnih simptomih, kot so znojenje, nespečnost, tresenje, občutek tesnobe, slabost ali bruhanje.
English: Temporal association of olanzapine treatment and venous thromboembolism has been reported uncommonly (≥ 0.1% and < 1%).
Slovenian: Občasno (≥ 0.1% in < 1%) so poročali o pojavu venske trombembolije (VTE) med zdravljenjem z olanzapinom, vendar vzročne povezave niso ugotovili.
English: Olanzapine was not mutagenic or clastogenic in a full range of standard tests, which included bacterial mutation tests and in vitro and in vivo mammalian tests.
Slovenian: Standardni testi, med katerimi so bili tudi testi mutiranja bakterij ter testi in vitro in in vivo na sesalcih, niso potrdili mutagenosti in klastogenosti olanzapina.
English: Zalasta 2.5 mg tablets Each tablet contains 2.5 mg olanzapine.
Slovenian: Zalasta 2,5 mg tablete Ena tableta vsebuje 2,5 mg olanzapina.
English: Other medicines and Zalasta
Slovenian: Druga zdravila in zdravilo Zalasta
English: Zalasta 7.5 mg tablets Each tablet contains 7.5 mg olanzapine.
Slovenian: Zalasta 7,5 mg tablete Ena tableta vsebuje 7,5 mg olanzapina.